Search results for "Alzheimer’s treatment"

Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003

Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003

Rznomics, a biopharmaceutical company specializing in RNA-based gene therapies, announced on the 24th that it has received a decision to grant a U. S.
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques

GemVax & Kael announced on June 10 that a study detailing the therapeutic mechanism of its Alzheimer’s disease drug candidate, GV1001, has been...
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment

Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects

A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key

Mild Cognitive Impairment Doesn’t Always Lead to Dementia—Early Diagnosis and Lifestyle Management Are Key

Sept. 21 marks Dementia Overcoming Day, a designated observance created to raise public awareness about preventing and...
When You Can’t Recall

When You Can’t Recall "Madeleine": Short Film Youngsikxty Spotlights Early Dementia Awareness

“Less ice in the oat latte… and, you know, that thing. What is it, the yellow round thing.
Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits

The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound...
Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea Taps Pharma Veteran Kim Chul-woong as New Country Lead

Biogen Korea has appointed Kim Chul-woong as its new general manager, tapping an executive with extensive expertise in...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent...